XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Capital stock
Capital in excess of par value
Retained earnings
Accumulated foreign currency adjustment attributable to parent
Accumulated defined benefit plans adjustment attributable to parent
Accumulated other comprehensive (loss) income
Treasury stock
Balance at the beginning of the year at Dec. 31, 2022   $ 2,700 $ 1,094,236 $ 8,857,485 $ (368,124) $ (206,821)   $ (1,902,964)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   4            
Issuance of common stock under employee stock plans     (12,153)         14,266
Share-based compensation expense     10,279          
Net income $ 305,712     305,712        
Cash dividends paid       (57,492)        
Other       0        
Translation adjustments         32,820      
Change in long-term intercompany notes         3,771      
Net investment hedge instruments gain (loss), net of tax of $(3,987) and $3,805 for the quarter ended March 31, 2024 and 2023, respectively         (11,684)      
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended March 31, 2024 and 2023, respectively           1,592    
Purchase of treasury stock               (6,502)
Balance at the end of the year at Mar. 31, 2023 7,757,125 2,704 1,092,362 9,105,705 (343,217) (205,229) $ (548,446) (1,895,200)
Balance at the beginning of the year at Dec. 31, 2023 8,730,191 2,709 1,168,694 9,940,343 (298,835) (186,107)   (1,896,613)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Shares issued   6            
Issuance of common stock under employee stock plans     8,497         6,603
Share-based compensation expense     8,941          
Net income 310,943     310,943        
Cash dividends paid       (64,664)        
Other       (1)        
Translation adjustments         (34,115)      
Change in long-term intercompany notes         (4,673)      
Net investment hedge instruments gain (loss), net of tax of $(3,987) and $3,805 for the quarter ended March 31, 2024 and 2023, respectively         12,242      
Amortization of net actuarial loss and other, net of tax of $(365) and $(518) for the quarter ended March 31, 2024 and 2023, respectively           1,160    
Purchase of treasury stock               (6,915)
Balance at the end of the year at Mar. 31, 2024 $ 8,968,215 $ 2,715 $ 1,186,132 $ 10,186,621 $ (325,381) $ (184,947) $ (510,328) $ (1,896,925)